Bibliographic Details
Title: |
736 A phase 1/2 open-label, dose-escalation study of ST-067, a decoy-resistant IL-18 cytokine, given as a monotherapy and with pembrolizumab in advanced solid tumor malignancies |
Authors: |
Mario Sznol, Harriet Kluger, Igor Puzanov, Gerald S Falchook, Ryan Sullivan, Matthew H Taylor, Justin C Moser, Aaron M Ring, Virginia E Paton, David Chonzi, Brage Garofalo, Mark Sonnemann, Hirdesh Uppal, Jeremy Barton, Beatrice Y McQueen |
Source: |
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023) |
Publisher Information: |
BMJ Publishing Group, 2023. |
Publication Year: |
2023 |
Collection: |
LCC:Neoplasms. Tumors. Oncology. Including cancer and carcinogens |
Subject Terms: |
Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282 |
Document Type: |
article |
File Description: |
electronic resource |
Language: |
English |
ISSN: |
2051-1426 |
Relation: |
https://doaj.org/toc/2051-1426 |
DOI: |
10.1136/jitc-2023-SITC2023.0736 |
Access URL: |
https://doaj.org/article/c9d6a589d3ec4c688bdb430c28cf8a3d |
Accession Number: |
edsdoj.9d6a589d3ec4c688bdb430c28cf8a3d |
Database: |
Directory of Open Access Journals |